###begin article-title 0
###xml 57 76 57 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 57 75 <span type="species:ncbi:5821">Plasmodium berghei</span>
Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 12 22 12 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
###xml 161 170 161 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 238 260 238 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 631 639 631 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 755 766 755 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 238 259 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Adhesion of Plasmodium-infected red blood cells (iRBC) to different host cells, ranging from endothelial to red blood cells, is associated to malaria pathology. In vitro studies have shown the relevance of CD36 for adhesion phenotypes of Plasmodium falciparum iRBC such as sequestration, platelet mediated clumping and non-opsonic uptake of iRBC. Different adhesion phenotypes involve different host cells and are associated with different pathological outcomes of disease. Studies with different human populations with CD36 polymorphisms failed to attribute a clear role to CD36 expression in human malaria. Up to the present, no in vivo model has been available to study the relevance of different CD36 adhesion phenotypes to the pathological course of Plasmodium infection.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 204 208 204 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 357 376 357 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 357 375 <span type="species:ncbi:5821">Plasmodium berghei</span>
Using CD36-deficient mice and their control littermates, CD36 bone marrow chimeric mice, expressing CD36 exclusively in haematopoietic cells or in non-haematopoietic cells, were generated. Irradiated CD36-/- and wild type mice were also reconstituted with syngeneic cells to control for the effects of irradiation. The reconstituted mice were infected with Plasmodium berghei ANKA and analysed for the development of blood parasitaemia and neurological symptoms.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
All mice reconstituted with syngeneic bone marrow cells as well as chimeric mice expressing CD36 exclusively in non-haematopoietic cells died from experimental cerebral malaria between day 6 and 12 after infection. A significant proportion of chimeric mice expressing CD36 only in haematopoietic cells did not die from cerebral malaria.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 73 89 73 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei ANKA </italic>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 73 83 <span type="species:ncbi:5821">P. berghei</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
The analysis of bone marrow chimeric mice reveals a dual role of CD36 in P. berghei ANKA infection. Expression of CD36 in haematopoietic cells, most likely macrophages and dendritic cells, has a beneficial effect that is masked in normal mice by adverse effects of CD36 expression in non-haematopoietic cells, most likely endothelial cells.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 30 41 30 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1109 1110 1109 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1269 1271 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1272 1274 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1308 1310 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1502 1503 1502 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1504 1505 1504 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1657 1658 1657 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1808 1810 1808 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1811 1813 1811 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1756 1761 <span type="species:ncbi:9606">human</span>
###xml 1859 1864 <span type="species:ncbi:9606">human</span>
Malaria is the consequence of Plasmodium infection that occurs in a variety of forms, affecting many organs, with different pathological and clinical features [1]. The mechanisms behind the pathogenesis of the various disease syndromes remain poorly understood. The interactions of infected red blood cells (iRBC) with various cells of the host (often referred to as adhesion phenotypes) are thought to be involved in several features of the disease. The accumulation of iRBC in the microvasculature of various organs is believed to protect the parasite from elimination by the spleen and to be a prominent cause of organ-specific malaria syndromes [2]. Non-opsonic phagocytosis is thought to eliminate parasites in a non-inflammatory manner that is reminiscent of the removal of apoptototic cells [3-8]. Several host cells that are involved in iRBC adhesion phenotypes are also involved in general inflammation processes and immune responses of the host. CD36 is a multiligand scavenger receptor that is expressed by many of these cells such as endothelial cells, platelets, dendritic cells and macrophages [9], as well as on both erythroid precursors [10] and normal erythrocytes [11,12]. Adhesion phenotypes involving CD36 include iRBC binding to endothelial cells [13,14] and platelet mediated clumping [15], both of which contribute to the occlusion of the microvasculature in target organs. Non-opsonic uptake of iRBC contributes to the clearance of parasites and modulation of phagocytic cells [3-8]. Thus, CD36 is involved in a variety of host-parasite interactions that may be protective and harmful to both the host and the parasite (reviewed in [8]). Moreover, studies attempting to associate severe malaria syndromes with CD36 polymorphisms in human populations have yielded conflicting results [16-18]. Thus, the role of CD36 in the pathology of human malaria remains elusive and CD36-mediated adhesion cannot be considered as a validated target for anti-malarial intervention.
###end p 11
###begin p 12
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
In the present work, CD36 bone marrow chimeric mice were generated to dissect and measure the contribution of CD36 expression by resident cells versus its role in circulating cells to disease outcome. The exclusive expression of CD36 in haematopoietic cells resulted in 25% protection from experimental cerebral malaria (ECM). In wild type mice this protective effect appears to be counteracted by CD36 expression in non-haematopoietic cells. These results indicate that, to be effective, agents that target CD36-binding for malaria intervention need to be cell-type specific, a requirement that cannot readily be met by present day technologies of drug development.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, parasites and infection
###end title 14
###begin p 15
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 133 135 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 178 197 178 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 178 196 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">Mice</span>
Seven to nine-week old male CD36-deficient mice (C57Bl/6 background) [19] and their wild type littermates were infected with fresh 106 green fluorescent protein (GFP)-expressing Plasmodium berghei ANKA iRBCs [20] by intra-peritoneal (i.p.) injection, after one passage through mice infected from a frozen vial. Peripheral blood parasitaemia was determined by flow cytometry and expressed as percentage of infected red blood cells, as described elsewhere [20]. Mice were observed for cerebral complications, i.e ataxia, paralysis, deviation of the head and convulsions, coma and death.
###end p 15
###begin title 16
###xml 26 30 <span type="species:ncbi:10090">mice</span>
CD36 bone marrow chimeric mice
###end title 16
###begin p 17
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 82 86 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 109 113 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 122 126 118 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 143 147 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 170 174 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 183 186 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 257 261 253 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 306 310 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 315 319 311 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 328 332 324 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 349 353 345 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 376 380 372 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 389 393 385 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 447 448 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
CD36-/- mice were lethally gamma-irradiated (900 rads) and reconstituted with CD36+/+ bone marrow cells (CD36+/+ into CD36-/- chimeras) or CD36-/- bone marrow cells (CD36-/- into CD36+/+). Reverse chimeric mice were also created by lethally irradiating CD36+/+ mice and reconstituting them with either CD36-/- (CD36-/- into CD36+/+ chimeras) or CD36+/+ bone marrow cells (CD36+/+ into CD36+/+ chimeras). Bone marrow cells from donor mice (6.5 x 106) were injected into each recipient mouse through the retro-orbital venous plexus one to five hours after irradiation. Chimeric animals were allowed to recover for five weeks before infection was initiated as described above. Depletion of circulating cells and reconstitution with donor cells was confirmed in all chimeric mice by PCR of blood genomic DNA. Blood was collected from the tail and DNA extracted using QIAamp DNA Micro Kit (Qiagen). PCR was performed using PCR Master Mix (Promega kit) and a set of three primers that amplify sequence either from the wild type (600 bp) or knockout (750-800 bp) allele. The following oligonucleotides (5'-3') were used for specific amplification: CAGCTCATACATTGCTGTTTATGCATG, GGTACAATCACAGTGTTTTCTACGTGG and CCGCTTCCTCGT GCTTTACGGTATC. Amplification program: 95degrees 4 min-1 cycle; 94degrees 1 min, 65degrees 1 min, 72degrees 2 min- 30 cycles; 4degrees infinity.
###end p 17
###begin title 18
Results and discussion
###end title 18
###begin p 19
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 148 170 148 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 250 264 250 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 536 547 536 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 579 590 579 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 782 793 782 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 148 169 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 250 263 <span type="species:ncbi:5833">P. falciparum</span>
###xml 389 395 <span type="species:ncbi:9606">humans</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
###xml 571 577 <span type="species:ncbi:9606">humans</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 782 792 <span type="species:ncbi:5821">P. berghei</span>
CD36 is expressed by both haematopoietic and non-haematopoietic cells [9-12]. CD36 is not only an important mediator of microvessels obstruction by Plasmodium falciparum iRBC, but also required for the non-opsonic phagocytosis of different stages of P. falciparum iRBC [4,5,21,22]. No consensus has been reached regarding the role of CD36 in the development of severe malaria syndromes in humans [8,23]. Since rodent malaria iRBCs also bind CD36 [24,25], mouse models may be used to study the requirement of CD36 in various features of Plasmodium infection [26]. Like in humans, Plasmodium infection of mice results in different pathologies that depend on the genomes of both the parasite and the host [26,27]. Previous work has shown that CD36 is essential for the accumulation of P. berghei ANKA iRBC in the lungs and adipose tissues, but has no role in the development of parasitaemia and the lethal course of ECM [25].
###end p 19
###begin p 20
###xml 201 205 201 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 480 491 480 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 655 659 655 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 668 672 668 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 804 808 804 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 988 992 986 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1001 1005 999 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1043 1045 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1121 1123 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 1268 1270 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1275 1277 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 480 490 <span type="species:ncbi:5821">P. berghei</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
To further define the role of CD36 expression in circulating cells such as macrophages and DCs, CD36 chimeric mice were generated by bone marrow transplantation. To control for irradiation effects CD36-/- mice and wild-type mice were also reconstituted with syngeneic bone marrow cells. Five weeks after reconstitution, chimeras showed more than 90% chimerism, as determined by blood genomic DNA PCR (data not shown). The four groups of reconstituted mice were then infected with P. berghei ANKA parasites that induce ECM in mice with the C57BL6 background. The two groups of mice reconstituted with syngeneic bone marrow cells (Figure 1A and 1B) and CD36-/- into CD36+/+ chimeras (Figure 1A) died six to 12 days after infection with neurological symptoms like previously observed for non-irradiated CD36-/- and wild type C57BL/6 mice. However, a significant proportion (25.8 +/- 9.3 %, n = 31) of chimeras expressing CD36 exclusively in haematopoietic cells, but not in other cells (CD36+/+ into CD36-/- chimeras) did not develop ECM (Figure 1B). These mice survived ECM and died later with higher parasitaemias (Figure 1D). No differences were observed between each chimeric group and its syngenic control in the development of peripheral blood parasitaemia (Figure 1C and 1D). These findings suggest a small, but significant beneficial role for CD36 when expressed only in haematopoietic cells and an adverse effect when expressed elsewhere.
###end p 20
###begin p 21
###xml 0 123 0 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bone marrow chimeric mice with CD36 expression confined to lethal radiation-sensitive cells are partially protected from CM</bold>
###xml 178 182 178 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 191 195 191 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 212 216 212 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 260 271 260 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 340 344 340 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 353 357 353 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 374 378 374 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 387 391 387 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 422 433 422 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 645 648 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 650 658 650 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CD36-/- </sup>
###xml 666 669 666 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 671 679 671 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CD36+/+ </sup>
###xml 736 738 736 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 766 770 766 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 779 782 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 790 794 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 803 806 803 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 814 818 814 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 827 830 827 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 851 854 851 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 260 270 <span type="species:ncbi:5821">P. berghei</span>
###xml 422 432 <span type="species:ncbi:5821">P. berghei</span>
Bone marrow chimeric mice with CD36 expression confined to lethal radiation-sensitive cells are partially protected from CM. (A) Cumulative survival and parasitaemias (C) of CD36+/+ into CD36+/+ (n = 11) and CD36-/- into CD36+/+ (n = 11) through the course of P. berghei ANKA infection. (B) Cumulative survival and parasitaemias (D) of CD36+/+ into CD36-/- (n = 31) and CD36-/- into CD36-/- (n = 18) through the course of P. berghei ANKA infection. Survival curves represent the summary of four of independent experiments. Parasitaemia curves are from one representative experiment out of the four performed. In two independent experiments, CD36+/+bmCD36-/- and CD36-/-bmCD36+/+ were generated and infected at same time. LOG-RANK Test: P < .001 for curve (B). ● CD36+/+ into CD36+/+, o CD36-/- into CD36+/+, ◆ CD36-/- into CD36-/-, ◇ CD36+/+ into CD36-/-. Gray area represents the time window for ECM development.
###end p 21
###begin p 22
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 384 388 384 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 397 401 397 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 480 484 480 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 493 497 493 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
CD36-mediated adhesion phenotypes involving haematopoietic cells include non-opsonic phagoytosis of iRBC by macrophages and dendritic cells and platelet mediated clumping. The later contributes to the obstruction of the microvasculature [15,28] and thus it is unlikely to be responsible for the beneficial effect of CD36 expression in haematopoietic cells that is apparent in the CD36+/+ into CD36-/- chimeras. Whether additional abrogation of CD36 expression in platelets of CD36+/+ into CD36-/- chimeras would lead to a higher protection still remains to be elucidated.
###end p 22
###begin p 23
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 850 852 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1114 1125 1106 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 282 288 <span type="species:ncbi:9606">humans</span>
The present study provides the first in vivo evidence, albeit indirect, that non-opsonic phagocytosis of iRBC by macrophages and dendritic cells may have a beneficial effect in malaria infections and reduce the risk of development of ECM. In non-chimeric animals, as it might be in humans, this beneficial effect of CD36 is apparently offset, by adverse effects of CD36 expression in non-haematopoietic cells, such as endothelial cells. Our results suggest that therapeutic effects could only be achieved by either up-regulating CD36 expression in macrophages and dendritic cells and/or by downregulating CD36 expression by endothelial cells. A recent study has shown that CD36 expression and phagocytosis of iRBC could be selectively up-regulated by agonists of the peroxisome proliferator activated receptor gamma (PPARgamma) such as troglitazone [29]. Such selective up-regulation of CD36 in macrophages and dendritic cells may shift the balance towards the beneficial effects of CD36. However, this approach is not likely to have a significant effect in endemic areas where the populations have developed anti-Plasmodium antibodies and are thus less dependent on non-opsonic phagocytosis.
###end p 23
###begin title 24
Conclusion
###end title 24
###begin p 25
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 252 265 252 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 301 321 301 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium chabaudi </italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 330 341 330 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 596 607 596 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 57 63 <span type="species:ncbi:9606">humans</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 252 265 <span type="species:ncbi:5833">P. falciparum</span>
###xml 301 320 <span type="species:ncbi:5825">Plasmodium chabaudi</span>
###xml 330 340 <span type="species:ncbi:5821">P. berghei</span>
###xml 358 363 <span type="species:ncbi:9606">human</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 596 606 <span type="species:ncbi:5821">P. berghei</span>
###xml 649 655 <span type="species:ncbi:9606">humans</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
Although clear differences between malaria infections in humans and mice exist, certain aspects of the infection are comparable [26]. CD36 expression and CD36-mediated adhesion of iRBCs to the microvasculature, for example, has been shown not only for P. falciparum, but also for the rodent parasites Plasmodium chabaudi [24] and P. berghei [25]. Studies on human populations polymorphisms for CD36 failed to define a clear role for CD36 in severe malaria syndromes [16-18]. The present study with bone marrow chimeric mice revealed both beneficial and adverse effects of CD36 in infections with P. berghei ANKA. Taken together with observations in humans, this study in mice indicates that CD36 is not a straightforward anti-malarial drug target and does not support further efforts to develop drugs that indiscriminately block all CD36 functions.
###end p 25
###begin title 26
Authors' contributions
###end title 26
###begin p 27
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
MCR performed all experimental work, with exception of mice genotyping, and participated both in the study design and manuscript drafting. SP performed mice genotyping, RNA extractions and helped on chimeric mice experiments. MF participated in the study design and manuscript drafting. MMM conceived the study and participated in its design and coordination as well as in manuscript drafting. MMM supervises MCR and SP. All authors read and approved the final manuscript.
###end p 27
###begin title 28
Acknowledgements
###end title 28
###begin p 29
We thank Werner Haas and Miguel Prudencio for critically reading this manuscript and Nuno Sepulveda for his help with the statistical analysis. This work was supported by Fundacao para a Ciencia e Tecnologia grant POCI/BIA-BCM/61799/2004 to MMM. MCR and SP are supported by FCT Fellowships, SFRH/BD/8435/2002 and SFRH/BD/31523/2006 respectively. MMM is a Fellow of the EMBO YIP and is a Howard Hughes Medical Institute International Research Scholar.
###end p 29
###begin article-title 30
###xml 37 45 <span type="species:ncbi:9606">children</span>
Pathophysiology of severe malaria in children
###end article-title 30
###begin article-title 31
Molecular aspects of malaria pathogenesis
###end article-title 31
###begin article-title 32
Recognizing death: the phagocytosis of apoptotic cells
###end article-title 32
###begin article-title 33
###xml 34 55 34 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 34 55 <span type="species:ncbi:5833">Plasmodium falciparum</span>
CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages
###end article-title 33
###begin article-title 34
###xml 47 68 47 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 47 68 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance
###end article-title 34
###begin article-title 35
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells
###end article-title 35
###begin article-title 36
Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells
###end article-title 36
###begin article-title 37
CD36 and malaria: friends or foes?
###end article-title 37
###begin article-title 38
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
###end article-title 38
###begin article-title 39
Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor
###end article-title 39
###begin article-title 40
###xml 63 84 63 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 63 84 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Involvement of CD36 on erythrocytes as arosetting receptor for Plasmodium falciparum-infected erythrocytes
###end article-title 40
###begin article-title 41
###xml 7 12 <span type="species:ncbi:9606">human</span>
Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells
###end article-title 41
###begin article-title 42
Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor
###end article-title 42
###begin article-title 43
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration
###end article-title 43
###begin article-title 44
###xml 30 50 30 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodiumfalciparum</italic>
Platelet-mediated clumping of Plasmodiumfalciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria
###end article-title 44
###begin article-title 45
Malaria susceptibility and CD36 mutation
###end article-title 45
###begin article-title 46
CD36 polymorphism is associated with protection from cerebral malaria
###end article-title 46
###begin article-title 47
###xml 64 85 64 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 64 85 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Cytoadherence, pathogenesis and the infected red cell surfacein Plasmodium falciparum
###end article-title 47
###begin article-title 48
###xml 19 25 <span type="species:ncbi:10090">murine</span>
A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
###end article-title 48
###begin article-title 49
###xml 2 21 2 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 2 20 <span type="species:ncbi:5821">Plasmodium berghei</span>
A Plasmodium berghei reference line that constitutivelyexpresses GFP at a high level throughout the complete life cycle
###end article-title 49
###begin article-title 50
###xml 98 119 98 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 98 119 <span type="species:ncbi:5833">Plasmodium falciparum</span>
CD36-mediated nonopsonic phagocytosis of erythrocytesinfected with stage I and IIA gametocytes of Plasmodium falciparum
###end article-title 50
###begin article-title 51
###xml 65 86 65 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 65 86 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Nonopsonic phagocytosis of erythrocytes infected with ring-stage Plasmodium falciparum
###end article-title 51
###begin article-title 52
Antimalarial drugs - host targets (re)visited
###end article-title 52
###begin article-title 53
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium chabaudi</italic>
###xml 0 19 <span type="species:ncbi:5825">Plasmodium chabaudi</span>
Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way
###end article-title 53
###begin article-title 54
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration
###end article-title 54
###begin article-title 55
Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis
###end article-title 55
###begin article-title 56
Immunological processes in malaria pathogenesis
###end article-title 56
###begin article-title 57
###xml 19 40 19 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 19 40 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells
###end article-title 57
###begin article-title 58
###xml 146 167 146 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 146 167 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Peroxisome proliferator-activatedreceptor gamma and retinoid X receptor agonists have minimal effectson the interaction of endothelial cells with Plasmodium falciparum-infected erythrocytes
###end article-title 58

